维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Poller DN"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? 显示文摘	Baxter K J Shepherd NA	1997	Br J Cancer1997，75，1：	1
2	p53 protein expression in human breast carcinoma:relationship to expression of epidermal growth factor receptor,c-erbB-2 protein over expression,and orstrogen receptor显示文摘	Poller DN Hutohings CE Galea M	1992	Br J Cancer1992，66，3：	1
3	Cathepsin D in primary breast carcinoma:Adverse prognosis is associated with expression of cathepsin D in stromal cells显示文摘	ODonaghue AEMA Poller DN Bell JA	1995	Breast Cancer Res Treat1995，33，：	1
4	Prognostic classification of breast ductal carcinoma in situ显示文摘	Poller DN Waisman JR	1995	Lancet1995，345，：	1
5	Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB2 oncoprotein 显示文摘	Poller DN Snead DR Roberts EC	1993	Br J Cancer1993，68，1：	1
6	Prognostic classification of breast duc- tal carcinoma-in-situ显示文摘	Silverstein MJ Poller DN waisman JR et al	1995	Lancet1995，345，：	1
7	Fine-needle aspirationofthe thyroid 显示文摘	Poller DN Ibrahim AK Cummings MH	2000	Cancer2000，90，4：	1
8	Oestrogen receptor expression in ductal carcinoma in situ of the breast:Rerlationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein显示文摘	Poller DN Snead DR Roberts EC	1993	Br J Cancer1993，68，：	1
9	Prognostic classification of breast ductal carcinomain-situ 显示文摘	Poller DN Waisman JR	1995	Lancet1995，345，：	1
10	Prognostic classification of breast ductal carcinoma in situ显示文摘	Silverstein M J Poller DN Waisman JR	1995	Lancet1995，345，8958：	1
11	Nuclear and Flow Cytometric Characteristics Associated with Over-expression of the c-erbB-2 Oncoprotein in Breast Carcinoma显示文摘	Galea M Pearson D	1991	Breast Cancer Res Treat1991，20，：	1
12	Prognostic classification of breast ductal carcinoma-in-situ显示文摘	Silverstein MJ Poller DN Waisman JR	1995	Lancet1995，345，9：	1
13	Prognostic classification of breast ductal carcinoma-in-situ显示文摘	Silverstein M J Poller DN Waisman JR	1995	Lancet1995，345，6：	1
14	Pathology of ductal carcinoma in situ of the breast:current status显示文摘	Poller DN	2005	Eur J Surg Oncol2005，27，5：	1
15	Prognostic classification of carcinoma-in-situ显示文摘	Silverstien MJ Poller DN Waisman JR	2006	Lancet2006，345，8569：	1
16	Thyroid FNAC cytology: can we do it better ? 显示文摘	Poller DN Stelow EB Yiangou C	2008	Cytopathology2008，19，1：	1
17	Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast 显示文摘	Silverstein MJ Barth A Poller DN	1995	Eur J Cancer1995，31，9：	1
18	New technology in thyroid fine-needle aspiration显示文摘	Poller DN	2014	J Clin Pathol2014，67，6：	1
19	BRAF V600 co-testing in thyroid FNA cytology: short-term experience in a large cancer centre in the UK显示文摘	Poller DN Glaysher S Agrawal A	2014	J Clin Pathol2014，67，8：	1
20	Nuclear and flow cytometric characteristics associated with over expression of the C-erhB-2 oncoprorein in breast carcinoma显示文摘	Poller DN Galea M Pearson D	1991	Breast Cancer Res Treat1991，20，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示